A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

We propose that there are existing treatments for the alleviation of negative symptoms, which may provide a novel treatment for patients with comorbid schizophrenia and cocaine abuse.

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use ...

(Jan. 10, 2019) --Researchers at UTSA have revealed significant insight into cocaine addiction, a phenomenon which has grown significantly in the United States since 2015. Now new data by UTSA shows ...

The rise in cocaine addiction among mothers often goes unnoticed due to stigma and fear of judgment, making it harder for women to seek the help they need.